Glucose Biosensor Market is anticipated to witness lucrative growth during the period of 2015 to 2022

Global Glucose Biosensor Market is expected to reach USD 31.0 billion by 2022, according to a new report by Grand View Research Inc. The global Glucose Biosensor Market is anticipated to witness lucrative growth during the period of 2015 to 2022. 

Some key factors attributing to the growth of this market include the increasing incidence of diabetes across the globe, development of technologically advanced products, growing demand for minimally and non-invasive products, patient awareness levels, and the need for early diabetes detection. However, presence of other alternatives for management of the diabetes, such as laboratory methods is expected to restrict market growth. 

The glucose biosensors industry by end-use is segmented on the basis of its use in hospitals, homecare diagnostics, and others including research institutes, diagnostics, and clinical laboratories. The homecare diagnostics Glucose Biosensor Market is projected to flourish over the forecast period. Ease-of-use, quick results, and low costs of the tests are some aspects supporting market growth. On the other hand, the hospital-based Glucose Biosensor Market is projected to grow at a significant CAGR of 10.3% during the period 2015 to 2022.

To request a sample copy or view summary of this report, click the link below:
http://www.grandviewresearch.com/industry-analysis/glucose-biosensors-market

Further key findings from the study suggest:

• North America led the market, in terms of value, with a share of about 37% in 2015. High disease burden and the subsequent need to curb associated healthcare expenditure in the U.S., has resulted in this country account for a large revenue share of the North American market in 2014. According to the Centers of Disease Control (CDC), around 22.3 million people in the U.S. were estimated to be diagnosed with diabetes in the year 2013.
• Asia Pacific is anticipated to witness lucrative growth during the forecast period. This market is projected to grow rapidly during the period 2015 to 2022. China and India are expected to spearhead market growth in this region.
• The homecare diagnostics Glucose Biosensor Market was the largest in 2014. The segment is anticipated to grow at a rapid CAGR during the forecast period. As of 2015, the market was led by North America owing to the region's highest disease burden and homecare diagnostics adoption rates.
• The Glucose Biosensor Market comprises several local as well as global players. Some major players of this industry include Roche, Bayer and LifeScan, Inc..